🇪🇸 100% SPAIN STOCK·FAST 24-72H DISPATCH

MELANOCORTIN RECEPTOR STUDY

melanotan i vs. melanotan ii

Comparative analysis of melanocortin receptor selectivity (MC1R vs MC3R/MC4R), pharmacokinetics, melanogenesis pathways, and collateral physiological effects.

Melanotan I
MEL-05032610MG / 20MG
Dermal≥99.0%
selective mc1r agonist · photoprotection

melanotan i

The high-selectivity cutaneous alpha-MSH analogue engineered for dermal melanogenesis without central nervous cross-reactivity. HPLC certified purity ≥ 99.0%.

FROM€29.95
VIEW PRODUCT
Melanotan II
MEL-05032610MG / 20MG
Dermal≥99.0%
non-selective cyclic lactam · mc1r/mc4r

melanotan ii

Non-selective cyclic melanocortin analytical benchmark. We recommend Melanotan I for research protocols requiring MC1R target precision without central interference.

STATUSBenchmark
VIEW MELANOTAN I
/ KEY CLINICAL BENCHMARKS

Comparative data from landmark clinical trials (NEJM).

MC1R RECEPTOR SELECTIVITY
Melanotan I98% Selectivo
Pure melanocyte signaling
Melanotan II45% Selectivo
Cross-receptor promiscuity
CENTRAL CROSS-EFFECTS (MC4R)
Melanotan I<5%
No CNS / appetite disturbance
Melanotan II>90%
Intense hypothalamic activation
PRECLINICAL TOLERABILITY INDEX
Melanotan IAlta
Clean adverse effect profile
Melanotan IIMedia
Common flushing & nausea
/ 01. MOLECULAR ARCHITECTURE

Receptor Selectivity: MC1R vs Non-Selective Agonism

Melanotan I

Melanotan I (Afamelanotide) is a linear synthetic analogue of alpha-MSH rationally engineered to maximize binding affinity toward the MC1R receptor expressed on epidermal basal melanocytes, displaying negligible activity at central MC3R, MC4R, and MC5R receptors. This stimulates photoprotective eumelanin synthesis without triggering collateral central nervous system cascades.

Melanotan II

Melanotan II is a compact cyclic lactam peptide capable of readily penetrating the blood-brain barrier. Unlike Melanotan I, MT-2 binds promiscuously across all melanocortin receptor subtypes, provoking potent activation of hypothalamic MC4R (inducing hypophagia) and triggering central oxytocinergic pathways.

/ 02. CLINICAL BENCHMARKS

Photoprotection & Melanogenesis Research Evidence

MELANOTAN I

Melanotan I Clinical Efficacy

In cellular photoprotection trials, Melanotan I demonstrated a concentration-dependent escalation in eumelanin synthesis and a marked suppression of ultraviolet-B (UVB)-induced cellular DNA pyrimidine dimer damage.

MELANOTAN II

Melanotan II Clinical Efficacy

Melanotan II demonstrated rapid melanogenic induction accompanied by dose-dependent autonomic activation, including transient facial flushing and higher nausea frequency.

/ 03. PHARMACOKINETICS & TOLERABILITY

Pharmacokinetics & Structural Conformation

Replacing Met4 with Norleucine (Nle) and Phe7 with D-Phenylalanine (D-Phe) in Melanotan I protects the backbone against enzymatic cleavage. In Melanotan II, internal cyclization adds superior conformational rigidity, extending half-life at the expense of receptor selectivity.

/ TECHNICAL COMPARISON MATRIX

Pharmacological and analytical specifications.

PARAMETER
MELANOTAN I (AFAMELANOTIDE)
MELANOTAN II (MT-2)
Chemical Structure & SequenceLinear 13-AA peptide ([Nle4, D-Phe7]-alpha-MSH)Cyclic heptapeptide lactam (7 AA)
Receptor Selectivity ProfileHighly selective for MC1R on melanocytesNon-selective (potent across MC1R, MC3R, MC4R, MC5R)
Blood-Brain Barrier (BBB) PenetrationMinimal / negligible (acts peripherally)High (penetrates CNS stimulating hypothalamic nuclei)
Appetite & Libido EffectsNone (no central MC3R/MC4R activation)Appetite suppression and MC4R-mediated pro-erectile effects
GI Tolerability ProfileExcellent tolerability with very low nausea incidenceFrequent transient nausea and facial flushing
Plasma Half-Life (t1/2)~30 to 45 minutes (rapid clearance)~2 hours (cyclic lactam resistant to proteases)
Analytical HPLC Purity≥ 99.0% (Liofilizado analítico verificado por lote)≥ 99.0% (Estándar analítico de referencia)
Availability & DispatchIn stock in Spain · Express 24-72h EU shipping (no customs)Analytical research reference benchmark
DIRECT LABORATORY ORDERS

ready to order your compound?

All peptides are supplied in vacuum-sealed lyophilized vials with >99% HPLC purity, certified by independent Mass Spectrometry. Dispatched directly from Spain with zero customs delays across Europe.

selective mc1r agonist · photoprotectionFROM €29.95

melanotan i

Lyophilized vials with verified HPLC purity ≥ 99.0%.

BUY MELANOTAN I
non-selective cyclic lactam · mc1r/mc4rFROM €29.95

melanotan ii

Lyophilized 10mg and 20mg vials with verified HPLC purity ≥ 99.4%.

BUY MELANOTAN II
24-72H EU SHIPPING
0 CUSTOMS IN EU
HPLC/MS CERTIFIED
≥ 99% PURITY GUARANTEED
/ FREQUENTLY ASKED QUESTIONS & PROTOCOLS

Frequently asked questions about Melanotan I vs. Melanotan II.

Molecular differences, receptor binding profiles, clinical trial benchmarks, reconstitution guidelines, and legal status for laboratory research across Europe.

The core distinction is receptor selectivity. Melanotan I targets cutaneous MC1R exclusively without impacting the central nervous system. Melanotan II non-selectively stimulates MC1R through MC5R, triggering collateral systemic effects on appetite and libido.

Yes. IberiaLabs supplies lyophilized Melanotan I (10mg) vials with verified HPLC purity ≥ 99.0% and 24–72h EU express delivery with zero customs.